logo

HLN

Haleon·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

HLN fundamentals

Haleon (HLN) expects to report earnings on Feb 27, 2025, with estimated revenue of 3.45B (YoY 0.00%), and EPS at 0.32 (YoY 0.00%).
Revenue estimate / YoY
3.45B
0.00%
EPS estimate / YoY
0.32
0.00%
Report date
Feb 27, 2025
HLN Earnings Call Summary for Q4,2024
  • Growth Drivers: 4-6% FY25 revenue growth fueled by Oral Health innovation (Clinical White expansion) and emerging markets (India/China JV).
  • Risk Management: 1% FX headwind offset by cost control; 13-day working capital improvement in FY24 with more gains possible.
  • Key Risks: Elevated cold/flu inventory in Q1, slow Eroxon launch, and US retail sector stress.
  • Strategic Focus: Capital allocation prioritizes growth (M&A) and returns (buybacks), with £500M buyback announced.
EPS
Revenue

Revenue & Expenses

HLN has released its 2024 Q4 earnings report, with revenue of 3.45B, reflecting a YoY change of -1.99%, and net profit of 277.97M, showing a YoY change of 3016.18%. The Sankey diagram below clearly presents HLN's revenue sources and cost distribution.

Key Indicators

Haleon (HLN) key financial stats and ratios, covering profitability, financial health, and leverage.
Haleon (HLN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Haleon (HLN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Haleon (HLN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Haleon (HLN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Haleon (HLN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield